BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zheng FY, Yang KS, Min WC, Li XZ, Xing Y, Wang S, Zhang YS, Zhao QC. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis. World J Gastrointest Surg 2024; 16(2): 571-584 [PMID: 38463352 DOI: 10.4240/wjgs.v16.i2.571]
URL: https://www.wjgnet.com/2307-8960/full/v16/i2/571.htm
Number Citing Articles
1
Katelin Durham, Tyler Atagozli, David E. Elliott, M. Nedim Ince. Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily PracticeBiomedicines 2025; 13(2) doi: 10.3390/biomedicines13020491